Pioglitazone prevents acute and chronic cardiac allograft rejection.


BACKGROUND Peroxisome proliferator-activated receptor-gamma plays an important role in regulating inflammation. Although cardiac transplantation is an established therapy for patients with end-stage heart disease, allograft rejection is a major concern for long-term survival. We investigated the role of pioglitazone in acute and chronic rejection in a… (More)


8 Figures and Tables

Slides referencing similar topics